83 results on '"Shioyama Y"'
Search Results
2. Proton and Carbon Ion Radiotherapy for Operable Early-Stage Lung Cancer: 3-Year Results of a Prospective Nationwide Registry
3. Corrigendum to ‘Gefitinib induction followed by chemoradiotherapy in EGFR-mutant, locally advanced non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study’
4. Gefitinib induction followed by chemoradiotherapy in EGFR-mutant, locally advanced non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study
5. Hypofractionated Carbon Ion Radiotherapy for D’Amico High-risk Prostate Cancer; a Subset Analysis of a Phase II Clinical Trial
6. Induction gefitinib followed by standard chemoradiotherapy in locally advanced (LA) non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) activating mutations: The LOGIK0902/OLCSG0905 intergroup phase II study
7. Prognosis after Local Recurrence or Metastases in Medically Operable Stage I Non-Small Cell Lung Cancer Patients Treated By Stereotactic Body Radiotherapy
8. Single Nucleotide Polymorphisms of Inflammation-Related Genes As Predictive Risk Factors of Radiation Pneumonitis after Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer
9. A Phase II Trial of Stereotactic Body Radiation Therapy for Operable T1N0M0 Non-Small Cell Lung Cancer; Japan Clinical Oncology Group (JCOG0403); Long Term Follow-up Results
10. Quality of Life Outcome in Patients with Localized Prostate Cancer after Hypofractionatied Carbon-Ion Radiation Therapy
11. Results of Hypofractionated Carbon-Ion Radiation Therapy for Peripherally Located Stage I Non-Small-Cell Lung Cancer
12. EP-1385: Carbon-ion radiotherapy for peripheral lung tumors in patients with severe pulmonary dysfunction
13. MS 24.04 Possibility of Radiotherapy for GGO-Containing Tumors
14. Radiation Pneumonitis and Change of Pulmonary Function after Stereotactic Body Radiotherapy for T1N0M0 Non-Small Cell Lung Cancer and Their Impact on Survival in a Supplementary Analysis of Japan Clinical Oncology Group (JCOG) Study JCOG0403
15. EP-1058: A multicenter study of carbon-io n RT for locally advanced olfactory neuroblastomas (JCROS1402HN)
16. PO-0690: An initial result of carbon-ion radiotherapy for metastatic liver tumors.
17. Short-Course carbon-ion radiation therapy for hepatocellular carcinoma: a nationwide survey by Japan Carbon Ion Radiation Oncology Study Group (J-CROS 1504)
18. Multi-institutional Retrospective Study of Carbon Ion Radiation Therapy for Stage I Non-Small Cell Lung Cancer: Japan Carbon Ion Radiation Oncology Study Group
19. Dosimetric Analysis of Upper Gastrointestinal Ulcer After Carbon Ion Radiation Therapy for Pancreatic Cancer
20. A Multi-institutional Analysis of Prospective Studies of Carbon Ion Radiation Therapy for Prostate Cancer: An Analysis of 2157 Patients from the Japan Carbon Ion Radiation Oncology Study Group (J-CROS)
21. Excellent Survival! Multi-Institutional Study of Stereotactic Body Radiation Therapy for Medically Operable and Young (70 Years Old or Younger) Patients With Stage I Non-Small Cell Lung Cancer
22. Multi-institutional Study of Carbon Ion Radiation Therapy for Locally Advanced Pancreatic Cancer: Japan Carbon Ion Radiation Oncology Study Group (J-CROS) Study 1403
23. Pulmonary Interstitial Changes Is a Predictive Factor for Radiation Pneumonitis After Stereotactic Body Radiation Therapy for Lung Cancer Patients
24. A Phase I Study of Stereotactic Body Radiation Therapy for Centrally Located Stage IA Non-Small Cell Lung Cancer
25. Comparison of Treatment Planning for Carbon Ion Radiation Therapy, Proton Therapy and Intensity Modulated Radiation Therapy for Spinal Tumors Encircling the Spinal Cord
26. Japanese Multi-institutional Study of Stereotactic Body Radiation Therapy for 661 Medically Operable Patients With Stage I Non-Small Cell Lung Cancer
27. Stereotactic Body Radiation Therapy for Histologically Confirmed Stage I Non-Small Cell Lung Cancer: Treatment Results and Patterns of Recurrence
28. Dose-Escalation Study of Stereotactic Body Radiation Therapy (SBRT) for Peripheral T2N0M0 Non-Small Cell Lung Cancer (NSCLC) With PTV ≥ 100 cm3: Japan Clinical Oncology Group Study (JCOG0702)
29. Multi-institutional Retrospective Study of Stereotactic Body Radiation Therapy for Stage I Small Cell Lung Cancer: Japan Radiation Oncology Study Group (JROSG)
30. Treatment Outcome of Primary Ocular Adnexal MALT Lymphoma by Radiation Therapy: Prognostic Effect of the AJCC Tumor-Node-Metastasis Clinical Staging System for Ocular Adnexal MALT Lymphoma
31. Stereotactic Body Radiation Therapy for Patients 90 Years or Older With Stage I Non-Small Cell Lung Cancer
32. Stereotactic Body Radiation Therapy for Patients With Pulmonary Interstitial Change
33. Incidence of Radiation Pneumonitis After Multiple Courses of Stereotactic Body Radiation Therapy for Lung Cancer Patients
34. Stereotactic Body Radiation Therapy for Stage I Small Cell Lung Cancer: Clinical Outcomes in a Japanese Multi-institutional Retrospective Study
35. Spontaneous Pneumothorax After Stereotactic Body Radiation Therapy for Lung Tumor
36. A Phase 1 Study of Stereotactic Body Radiation Therapy (SBRT) for Peripheral T2N0M0 Non-Small Cell Lung Cancer (NSCLC): Japan Clinical Oncology Group Study (JCOG0702)
37. Carcinoembryonic Antigen as a Predictive Factor for Recurrence After Stereotactic Body Radiation Therapy in Stage I Lung Adenocarcinoma
38. Acute Cardiac Impairment Associated With Concurrent Chemoradiation Therapy for Esophageal Cancer
39. Stereotactic Body Radiation Therapy For T1N0M0 Non-small Cell Lung Cancer: First Report for Inoperable Population of a Phase II Trial by Japan Clinical Oncology Group (JCOG 0403)
40. Usefulness of Electron Density in Gross Tumor Volume as a Prognostic Factor in Stage I Non-small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy
41. Acquired Resistance to EGFR Tyrosine Kinase Inhibitors is Associated With Low Efficacy of Radiation Therapy for Brain Metastases From EGFR-mutant Lung Adenocarcinoma
42. Prognostic Value of FDG-PET in Definitive Chemoradiation Therapy for Esophageal Cancer
43. Can Belly Board Reduce Respiratory-induced Prostate Motion in the Prone Position? Assessed by Cine-magnetic Resonance Imaging
44. Limited-Stage Diffuse Large B-cell Lymphoma in Head and Neck Treated With CHOP or Rituximab-CHOP (R-CHOP) Plus Radiation Therapy
45. Stereotactic Body Radiation Therapy in 95 Patients With Lung Tumors Composed of Ground-glass Opacity (GGO): Results of a Retrospective Multicenter Study
46. Real-time Monitoring Of A Lung Tumor Region Based On Gamma Evaluation Using Portal Dose Cine Images During Stereotactic Body Radiotherapy
47. Computerized Estimation of Possible Clinical Target Volume Based on Multimodality Images using a Dual Active Contour Model
48. Fractionated Re-irradiation For Local Recurrence Following Stereotactic Body Radiotherapy For Primary And Metastatic Lung Cancers
49. Optimization Of Robust Beam Angles To Patient Setup Errors For Head and Neck Cancer In Hadron Particle Therapy
50. Treatment Efficacy Of Preoperative Chemoradiotherapy For Patients With Locally Advanced Non-small cell Lung Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.